AstraZeneca beats Q3 estimates on oncology strength (AZN:NASDAQ)
AstraZeneca (AZN) posted stronger-than-expected Q3 results, fueled by continued strength in its oncology portfolio. The U.K. drugmaker reported adjusted EPS ...
Saturday, June 6, 2026
Tag: AZNNASDAQ
-1024x768.jpg "Red Snapper Used as Cudgel by Fed Judge")
The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.